CJC-1295 (No DAC)
Modified GRF (1–29) analogue without the drug affinity complex, studied for GHRH receptor activity.
$36.9910 mg
1 vial5-pack −10%10-pack −20%
Growth hormone axis · Research peptide · Canada
Tesamorelin
Stabilized GHRH (1–44) analogue with a trans-3-hexenoic acid modification.
Labelled amount
Pack
FormLyophilized powder
Molecular weight5135.9 g/mol
CAS218949-48-5
PurityManufacturer HPLC result stated on the batch COA. Look up a lot →
StorageLyophilized: −20 °C, protected from light. Reconstituted: 2–8 °C.
Supplied asSingle sealed glass vial with printed lot number. Sold per vial or in 5- and 10-packs.
Research topics
GHRH analogue stabilityVisceral adipose models
Research use onlyThis product is a research chemical supplied for in-vitro laboratory use by qualified personnel. It is not approved by Health Canada, is not a drug, and is not for human or veterinary use. Reference values (MW, CAS) are literature values for the base compound; confirm identity and purity against the batch COA.
Related
Full catalogueAlso in growth hormone axis
Ipamorelin
Selective pentapeptide ghrelin-receptor agonist used in secretagogue research.
$54.99 – $73.995 mg · 10 mg
1 vial5-pack −10%10-pack −20%
Sermorelin
GHRH (1–29) amide, the reference GHRH fragment in secretagogue research.
$49.99 – $68.995 mg · 10 mg
1 vial5-pack −10%10-pack −20%
Retatrutide
Investigational triple agonist studied at the GIP, GLP-1 and glucagon receptors.
$59.99 – $275.995 mg · 10 mg · 30 mg · 50 mg · 60 mg
1 vial5-pack −10%10-pack −20%